IMC Chicago
AZN icon

IMC Chicago’s AstraZeneca AZN Stock Holding History

IMC Chicago’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.2M Buy
193,700
+53,500
+38% +$10.3M 0.01% 594
2025
Q4 		$25.8M Buy
140,200
+12,650
+10% +$2.22M 0.01% 737
2025
Q3 		$19.6M Buy
127,550
+22,550
+21% +$3.41M 0.01% 800
2025
Q2 		$14.7M Sell
105,000
-41,250
-28% -$5.78M 0.01% 831
2025
Q1 		$21.5M Buy
146,250
+30,350
+26% +$4.39M 0.01% 543
2024
Q4 		$15.2M Buy
115,900
+51,050
+79% +$7.15M 0.01% 725
2024
Q3 		$10.1M Sell
64,850
-19,350
-23% -$3.12M 0.01% 821
2024
Q2 		$13.1M Buy
84,200
+21,000
+33% +$3.16M 0.01% 679
2024
Q1 		$8.56M Buy
63,200
+10,450
+20% +$1.38M 0.01% 765
2023
Q4 		$7.11M Sell
52,750
-11,450
-18% -$1.49M ﹤0.01% 761
2023
Q3 		$8.7M Buy
64,200
+10,350
+19% +$1.41M 0.01% 589
2023
Q2 		$7.71M Buy
53,850
+18,050
+50% +$2.66M 0.01% 563
2023
Q1 		$4.97M Sell
35,800
-6,200
-15% -$834K 0.01% 650
2022
Q4 		$5.7M Buy
42,000
+1,350
+3% +$169K 0.01% 582
2022
Q3 		$4.46M Sell
40,650
-6,750
-14% -$856K 0.01% 586
2022
Q2 		$6.26M Sell
47,400
-5,950
-11% -$781K 0.01% 517
2022
Q1 		$7.08M Sell
53,350
-24,800
-32% -$2.97M 0.01% 522
2021
Q4 		$9.1M Buy
78,150
+22,700
+41% +$2.67M 0.01% 500
2021
Q3 		$6.66M Sell
55,450
-19,800
-26% -$2.3M 0.01% 572
2021
Q2 		$9.02M Sell
75,250
-20,700
-22% -$2.27M 0.01% 473
2021
Q1 		$9.54M Sell
95,950
-61,000
-39% -$6.13M 0.01% 439
2020
Q4 		$15.7M Buy
156,950
+82,450
+111% +$8.73M 0.02% 317
2020
Q3 		$8.16M Buy
+74,500
New +$8.29M 0.01% 339

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

IMC Chicago's AZN Position: Q4 2025 in Review

IMC Chicago sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 20,753 shares — an estimated $3.64M sold.

IMC Chicago first reported a position in AZN in Q4 2020 and held it in 4 quarters. The position peaked at $3.18M in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • IMC Chicago reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • IMC Chicago sold 20,753 AstraZeneca shares in Q4 2025, an estimated $3.64M.
  • IMC Chicago first reported a position in AstraZeneca in Q4 2020 and held it in 4 quarters.
  • IMC Chicago's AstraZeneca position peaked at $3.18M in Q3 2025.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.